SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 198 filers reported holding SANGAMO THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.70 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $23 | -65.2% | 39,485 | -23.2% | 0.00% | – |
| Q2 2023 | $66 | +37.5% | 51,430 | +88.4% | 0.00% | – |
| Q1 2023 | $48 | +45.5% | 27,302 | +158.3% | 0.00% | – |
| Q4 2022 | $33 | -100.0% | 10,571 | -62.0% | 0.00% | – |
| Q3 2022 | $136,000 | +177.6% | 27,782 | +131.6% | 0.00% | – |
| Q2 2022 | $49,000 | -80.2% | 11,994 | -71.8% | 0.00% | – |
| Q1 2022 | $247,000 | -37.3% | 42,540 | -19.1% | 0.00% | – |
| Q4 2021 | $394,000 | +41.2% | 52,552 | +125.6% | 0.00% | – |
| Q3 2021 | $279,000 | +1.5% | 23,294 | +1.3% | 0.00% | – |
| Q2 2021 | $275,000 | – | 22,994 | +55.9% | 0.00% | – |
| Q1 2021 | $0 | -100.0% | 14,746 | -75.8% | 0.00% | -100.0% |
| Q4 2020 | $948,000 | +244.7% | 60,812 | +108.5% | 0.00% | – |
| Q3 2020 | $275,000 | -52.2% | 29,172 | -54.6% | 0.00% | -100.0% |
| Q2 2020 | $575,000 | +283.3% | 64,240 | +171.3% | 0.00% | – |
| Q1 2020 | $150,000 | -67.2% | 23,682 | -56.7% | 0.00% | -100.0% |
| Q4 2019 | $458,000 | -1.3% | 54,727 | +6.7% | 0.00% | 0.0% |
| Q3 2019 | $464,000 | -14.9% | 51,289 | +1.2% | 0.00% | 0.0% |
| Q2 2019 | $545,000 | +505.6% | 50,659 | +436.1% | 0.00% | – |
| Q1 2019 | $90,000 | -80.5% | 9,450 | -76.5% | 0.00% | -100.0% |
| Q4 2018 | $461,000 | +60.6% | 40,180 | +136.9% | 0.00% | 0.0% |
| Q3 2018 | $287,000 | -60.1% | 16,960 | -66.6% | 0.00% | -66.7% |
| Q2 2018 | $720,000 | -24.8% | 50,743 | +0.7% | 0.00% | -92.9% |
| Q1 2018 | $957,000 | +11862.5% | 50,400 | +3040.2% | 0.04% | – |
| Q1 2017 | $8,000 | -92.9% | 1,605 | -87.0% | 0.00% | -100.0% |
| Q4 2015 | $112,000 | +133.3% | 12,368 | +43.4% | 0.01% | +125.0% |
| Q3 2015 | $48,000 | -88.6% | 8,624 | -68.0% | 0.00% | -91.8% |
| Q1 2015 | $422,000 | +549.2% | 26,946 | +531.2% | 0.05% | +512.5% |
| Q4 2014 | $65,000 | – | 4,269 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Golden State Equity Partners | 154,360 | $897,000 | 0.45% |
| Rhenman & Partners Asset Management AB | 761,429 | $4,424,000 | 0.44% |
| Lombard Odier Asset Management (Switzerland) SA | 860,702 | $5,001,000 | 0.39% |
| WASATCH ADVISORS LP | 10,576,997 | $61,452,000 | 0.30% |
| Rokos Capital Management LLP | 977,663 | $5,861,000 | 0.27% |
| KLK CAPITAL MANAGEMENT LLC | 44,323 | $258,000 | 0.26% |
| Long Focus Capital Management, LLC | 340,000 | $1,975,000 | 0.25% |
| Vanguard Capital Wealth Advisors | 33,380 | $193,000 | 0.14% |
| Fort Sheridan Advisors LLC | 73,978 | $430,000 | 0.13% |
| Delphia (USA) Inc. | 20,983 | $122,000 | 0.09% |